ADC Therapeutics
ZYNLONTA
Manufacturer:
ADC Therapeutics
Name:
ZYNLONTA
HCPCS Code Descriptor:
Injection, loncastuximab tesirine-lpyl, 0.075 mg
Category:
J Code
HCPCS:
J9359
NDC(s):
79952-0110-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ZYNLONTA is an Oncology drug manufactured by ADC Therapeutics and administered via the Intravenous route of administration. The J Code: J9359 is aligned to the drug ZYNLONTA.
Access Pricing and More By Registering
HCPCS Added Date:
4/1/22
HCPCS Effective Date:
4/1/22
HCPCS Short Description:
Inj lon tesirin-lpyl 0.075mg
Billing and Coding Guide:
https://www.zynlontahcp.com/wp-content/uploads/2022/03/Coding-and-Billing-Guide-Download-30822.pdf
Patient Assistance:
https://www.advancingpatientsupport.com/hcp/#enroll-your-patient-now